pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-4665 |
Genomic Coordinates | chr9: 6007826 - 6007904 |
Description | Homo sapiens miR-4665 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | |||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-4665-5p | ||||||||||||||||||||||||||||||||||||||||||
Sequence | 10| CUGGGGGACGCGUGAGCGCGAGC |32 | ||||||||||||||||||||||||||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||||||||||||||||||||||||||
Experiments | Illumina | ||||||||||||||||||||||||||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | ANKRD13B | ||||||||||||||||||||
Synonyms | - | ||||||||||||||||||||
Description | ankyrin repeat domain 13B | ||||||||||||||||||||
Transcript | NM_152345 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on ANKRD13B | |||||||||||||||||||||
3'UTR of ANKRD13B (miRNA target sites are highlighted) |
>ANKRD13B|NM_152345|3'UTR 1 CGCCCCCTGCCGGGACCCTCGCCAGCGCCACGCGCGCCACGCCCAGGGCCAGGAGCCAGACAAACCCCGGCCTGCGCGCC 81 TGCAGAGCGGCGGCTGGAGACTGGAGCCACCGCCTCGCGGGTGCAGCAGCACAGCAGGCACGGTTCGGGGAGGGATTCGG 161 CATGGCCGCGGGGTACCTTCCCAGGCCAGGGCCCTGGAGGCAACTGGCACGGCCTGGTCCCCCTGCTTTGCTGTATTCTG 241 ATTCCCCAACCCGCTCCCCTGGGCTCAGATCTGTCCTGTCCTAGGGCGGAGCCAGGCGGTCCTGAGGGGGAGATGAATCC 321 TTAGAGGAGCGCTGTCCCTATCCCTTGCTCCTTCTGGCCGGTCCGCATTTCTGTTCACTAACCCCACTCCAGGACACTGC 401 CCCTGAAGCCTTTGCATCTCTGCTCTTCACTCCTGGGGGGCAGCTGAGCTCCCCGCGTGCTGTGTCACTGCTTTGTTCCA 481 GACACAAACCAGCACGTCTAGGGCCCAGCCCCTCCCCCACCCCGGCATTTCAGCGTCAAGTGCACTTAGCGGGGTACCCG 561 GCTCCCCCAGCCCCCACACCCGTCCTGGGTCTCAGGGTGGTTCCAGCTTCTCCTTGGGCAGCCAGAAGTTGGAGTCCCAT 641 CCCCCAAGGCACATTTTTTTTTTTTTTTTTTTGTGATCAGGGAGTGTGTCCAACGTAGCCCCCTGGCCTGTGCAAGCCCT 721 GACTCCCTCATGGTGCCTCGGAGAGTGGGGAGCATATTGGGCTGGGGTAAGCACTAGACCCAAGTAGACTGGACACAAAG 801 GGCTCGCCCAGGGCCCTGGCGCCACCCCCACCCCTTCCCACCAGCTGCTGCTAGCCTCTGTGGTTGTACATCCCACTTGC 881 CCCCACACGGAGACTGACTCTAAAACCCTTCATCCAATGGTGCTAACCCCCGGCTCTCCCCTGCCCCACCTCACCCACCC 961 AGAGAAGCACAGACCCCGCCAGGGGCAGGGGCCCACCGCACACCCTTGTCCCGGGCCTGTCTGGGACTGGCCTTCCCGGC 1041 TCAGCCAGTGAGGCTCAGAAGGGACACAAAGAGGGATGGAAGAAAAGAACAAAGAGAAACTGTTCCTCCCACCCCCTTCC 1121 CTGATGCCAGGGGCACCAGACTGATTCTGAGGCACAAATAAAAGAGGCTTCATACCGGAAAAAAAAAAAAAAAAAAAAAA 1201 AAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM545215. RNA binding protein: AGO4. Condition:Control
... - Hafner M; Landthaler M; Burger L; Khorshid et al., 2010, Cell. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Hafner M; Landthaler M; Burger L; Khorshid et al. - Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | C8166 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462572. RNA binding protein: AGO2. Condition:C8166 NL4-3
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
Experimental Support 3 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HCT116 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in ERX177623. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_4_1
PAR-CLIP data was present in ERX177599. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_2_1
PAR-CLIP data was present in ERX177628. RNA binding protein: AGO2. Condition:p53_V_AGO_CLIP_4_6
PAR-CLIP data was present in ERX177634. RNA binding protein: AGO2. Condition:KO_V_AGO_CLIP_4_12
PAR-CLIP data was present in ERX177610. RNA binding protein: AGO2. Condition:KO_V_AGO_CLIP_2_12
PAR-CLIP data was present in ERX177622. RNA binding protein: AGO2. Condition:KO_V_AGO_CLIP_3_12
PAR-CLIP data was present in ERX177630. RNA binding protein: AGO2. Condition:KO_V_AGO_CLIP_4_8
... - Krell J; Stebbing J; Carissimi C; Dabrowska et al., 2016, Genome research. |
Article |
- Krell J; Stebbing J; Carissimi C; Dabrowska et al. - Genome research, 2016
DNA damage activates TP53-regulated surveillance mechanisms that are crucial in suppressing tumorigenesis. TP53 orchestrates these responses directly by transcriptionally modulating genes, including microRNAs (miRNAs), and by regulating miRNA biogenesis through interacting with the DROSHA complex. However, whether the association between miRNAs and AGO2 is regulated following DNA damage is not yet known. Here, we show that, following DNA damage, TP53 interacts with AGO2 to induce or reduce AGO2's association of a subset of miRNAs, including multiple let-7 family members. Furthermore, we show that specific mutations in TP53 decrease rather than increase the association of let-7 family miRNAs, reducing their activity without preventing TP53 from interacting with AGO2. This is consistent with the oncogenic properties of these mutants. Using AGO2 RIP-seq and PAR-CLIP-seq, we show that the DNA damage-induced increase in binding of let-7 family members to the RISC complex is functional. We unambiguously determine the global miRNA-mRNA interaction networks involved in the DNA damage response, validating them through the identification of miRNA-target chimeras formed by endogenous ligation reactions. We find that the target complementary region of the let-7 seed tends to have highly fixed positions and more variable ones. Additionally, we observe that miRNAs, whose cellular abundance or differential association with AGO2 is regulated by TP53, are involved in an intricate network of regulatory feedback and feedforward circuits. TP53-mediated regulation of AGO2-miRNA interaction represents a new mechanism of miRNA regulation in carcinogenesis.
LinkOut: [PMID: 26701625]
|
CLIP-seq Support 1 for dataset GSM545215 | |
---|---|
Method / RBP | PAR-CLIP / AGO4 |
Cell line / Condition | HEK293 / Control |
Location of target site | ENST00000394859.3 | 3UTR | CCUCCCCCACCCCGGCAU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM1462572 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | C8166 / C8166 NL4-3 |
Location of target site | ENST00000394859.3 | 3UTR | CUCCCCCACCCCGGCAU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
123 hsa-miR-4665-5p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT115350 | IGF1R | insulin like growth factor 1 receptor | 2 | 8 | ||||||||
MIRT144387 | SF3B3 | splicing factor 3b subunit 3 | 2 | 2 | ||||||||
MIRT145421 | ANKRD13B | ankyrin repeat domain 13B | 2 | 4 | ||||||||
MIRT146684 | MINK1 | misshapen like kinase 1 | 2 | 2 | ||||||||
MIRT178944 | C11ORF57 | chromosome 11 open reading frame 57 | 2 | 2 | ||||||||
MIRT189772 | CDADC1 | cytidine and dCMP deaminase domain containing 1 | 2 | 2 | ||||||||
MIRT238514 | HNRNPAB | heterogeneous nuclear ribonucleoprotein A/B | 2 | 2 | ||||||||
MIRT366308 | GDI1 | GDP dissociation inhibitor 1 | 2 | 4 | ||||||||
MIRT375173 | ARIH1 | ariadne RBR E3 ubiquitin protein ligase 1 | 2 | 2 | ||||||||
MIRT442321 | WNT9B | Wnt family member 9B | 2 | 2 | ||||||||
MIRT442581 | HOXD9 | homeobox D9 | 2 | 2 | ||||||||
MIRT451170 | PIN1 | peptidylprolyl cis/trans isomerase, NIMA-interacting 1 | 2 | 2 | ||||||||
MIRT451894 | ILK | integrin linked kinase | 2 | 2 | ||||||||
MIRT453620 | SLC4A2 | solute carrier family 4 member 2 | 2 | 2 | ||||||||
MIRT454769 | STOML3 | stomatin like 3 | 2 | 2 | ||||||||
MIRT455038 | MEN1 | menin 1 | 2 | 2 | ||||||||
MIRT455151 | SUV39H1 | suppressor of variegation 3-9 homolog 1 | 2 | 2 | ||||||||
MIRT456891 | DDA1 | DET1 and DDB1 associated 1 | 2 | 2 | ||||||||
MIRT457201 | THSD4 | thrombospondin type 1 domain containing 4 | 2 | 2 | ||||||||
MIRT457373 | CAMK2A | calcium/calmodulin dependent protein kinase II alpha | 2 | 2 | ||||||||
MIRT459190 | RCE1 | Ras converting CAAX endopeptidase 1 | 2 | 2 | ||||||||
MIRT462580 | MYL12A | myosin light chain 12A | 2 | 2 | ||||||||
MIRT464669 | UBE2V1 | ubiquitin conjugating enzyme E2 V1 | 2 | 2 | ||||||||
MIRT464753 | UBE2N | ubiquitin conjugating enzyme E2 N | 2 | 2 | ||||||||
MIRT464881 | UBALD1 | UBA like domain containing 1 | 2 | 2 | ||||||||
MIRT465932 | TMEM189-UBE2V1 | TMEM189-UBE2V1 readthrough | 2 | 2 | ||||||||
MIRT466013 | TMEM189 | transmembrane protein 189 | 2 | 2 | ||||||||
MIRT466905 | STK38 | serine/threonine kinase 38 | 2 | 10 | ||||||||
MIRT468421 | SETD1B | SET domain containing 1B | 2 | 2 | ||||||||
MIRT468592 | SERBP1 | SERPINE1 mRNA binding protein 1 | 2 | 2 | ||||||||
MIRT468853 | RREB1 | ras responsive element binding protein 1 | 2 | 2 | ||||||||
MIRT468900 | RPS6KA4 | ribosomal protein S6 kinase A4 | 2 | 2 | ||||||||
MIRT469189 | RICTOR | RPTOR independent companion of MTOR complex 2 | 2 | 2 | ||||||||
MIRT469305 | RGP1 | RGP1 homolog, RAB6A GEF complex partner 1 | 2 | 2 | ||||||||
MIRT469771 | RAB15 | RAB15, member RAS oncogene family | 2 | 2 | ||||||||
MIRT469934 | PTPRF | protein tyrosine phosphatase, receptor type F | 2 | 2 | ||||||||
MIRT470000 | PTPLB | 3-hydroxyacyl-CoA dehydratase 2 | 1 | 1 | ||||||||
MIRT470585 | POTEM | POTE ankyrin domain family member M | 2 | 2 | ||||||||
MIRT470615 | POTEG | POTE ankyrin domain family member G | 2 | 2 | ||||||||
MIRT470932 | PKM | pyruvate kinase, muscle | 2 | 2 | ||||||||
MIRT472511 | NACC1 | nucleus accumbens associated 1 | 2 | 2 | ||||||||
MIRT472843 | MTHFR | methylenetetrahydrofolate reductase | 2 | 2 | ||||||||
MIRT473298 | MEX3A | mex-3 RNA binding family member A | 2 | 2 | ||||||||
MIRT473951 | LRRC58 | leucine rich repeat containing 58 | 2 | 2 | ||||||||
MIRT474336 | KMT2D | lysine methyltransferase 2D | 2 | 2 | ||||||||
MIRT474399 | KLHL28 | kelch like family member 28 | 2 | 8 | ||||||||
MIRT476487 | GATAD2A | GATA zinc finger domain containing 2A | 2 | 2 | ||||||||
MIRT477597 | EFNA3 | ephrin A3 | 2 | 2 | ||||||||
MIRT477857 | DYRK2 | dual specificity tyrosine phosphorylation regulated kinase 2 | 2 | 2 | ||||||||
MIRT479858 | CCDC6 | coiled-coil domain containing 6 | 2 | 2 | ||||||||
MIRT480123 | CALR | calreticulin | 2 | 2 | ||||||||
MIRT480391 | C19orf47 | chromosome 19 open reading frame 47 | 2 | 2 | ||||||||
MIRT480685 | BRPF1 | bromodomain and PHD finger containing 1 | 2 | 2 | ||||||||
MIRT482326 | AGO2 | argonaute 2, RISC catalytic component | 2 | 2 | ||||||||
MIRT482513 | ACTB | actin beta | 2 | 2 | ||||||||
MIRT483244 | CITED4 | Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 4 | 2 | 4 | ||||||||
MIRT483282 | SLC35C2 | solute carrier family 35 member C2 | 2 | 4 | ||||||||
MIRT483381 | SPATA6 | spermatogenesis associated 6 | 2 | 4 | ||||||||
MIRT483416 | RHOXF2B | Rhox homeobox family member 2B | 2 | 2 | ||||||||
MIRT483468 | STMN3 | stathmin 3 | 2 | 4 | ||||||||
MIRT484178 | SUMO1 | small ubiquitin-like modifier 1 | 2 | 2 | ||||||||
MIRT484460 | DDX6 | DEAD-box helicase 6 | 2 | 2 | ||||||||
MIRT484515 | POLD3 | DNA polymerase delta 3, accessory subunit | 2 | 2 | ||||||||
MIRT484595 | SIX3 | SIX homeobox 3 | 2 | 6 | ||||||||
MIRT484738 | ABCC6 | ATP binding cassette subfamily C member 6 | 2 | 4 | ||||||||
MIRT485248 | PLEKHA3 | pleckstrin homology domain containing A3 | 2 | 2 | ||||||||
MIRT485592 | FOSL1 | FOS like 1, AP-1 transcription factor subunit | 2 | 4 | ||||||||
MIRT485912 | PGPEP1 | pyroglutamyl-peptidase I | 2 | 4 | ||||||||
MIRT485954 | RTBDN | retbindin | 2 | 2 | ||||||||
MIRT486597 | METTL6 | methyltransferase like 6 | 2 | 2 | ||||||||
MIRT486807 | NDOR1 | NADPH dependent diflavin oxidoreductase 1 | 2 | 2 | ||||||||
MIRT486972 | STEAP3 | STEAP3 metalloreductase | 2 | 4 | ||||||||
MIRT487364 | C10orf54 | V-set immunoregulatory receptor | 2 | 2 | ||||||||
MIRT488072 | DLGAP3 | DLG associated protein 3 | 2 | 4 | ||||||||
MIRT488150 | PRRC2B | proline rich coiled-coil 2B | 2 | 4 | ||||||||
MIRT488454 | B3GALNT2 | beta-1,3-N-acetylgalactosaminyltransferase 2 | 2 | 2 | ||||||||
MIRT489027 | PRPF4B | pre-mRNA processing factor 4B | 2 | 2 | ||||||||
MIRT489704 | CALML3 | calmodulin like 3 | 2 | 2 | ||||||||
MIRT489757 | GRINA | glutamate ionotropic receptor NMDA type subunit associated protein 1 | 2 | 2 | ||||||||
MIRT490015 | PIEZO1 | piezo type mechanosensitive ion channel component 1 | 2 | 2 | ||||||||
MIRT490120 | FN3K | fructosamine 3 kinase | 2 | 2 | ||||||||
MIRT490187 | PKNOX2 | PBX/knotted 1 homeobox 2 | 2 | 2 | ||||||||
MIRT490313 | ANK1 | ankyrin 1 | 2 | 4 | ||||||||
MIRT490595 | SLC47A1 | solute carrier family 47 member 1 | 2 | 4 | ||||||||
MIRT491133 | GRWD1 | glutamate rich WD repeat containing 1 | 2 | 2 | ||||||||
MIRT493027 | NAA50 | N(alpha)-acetyltransferase 50, NatE catalytic subunit | 2 | 2 | ||||||||
MIRT494199 | CLIP2 | CAP-Gly domain containing linker protein 2 | 2 | 2 | ||||||||
MIRT495699 | PADI1 | peptidyl arginine deiminase 1 | 2 | 2 | ||||||||
MIRT501149 | SLC10A7 | solute carrier family 10 member 7 | 2 | 6 | ||||||||
MIRT501413 | RAB11FIP4 | RAB11 family interacting protein 4 | 2 | 2 | ||||||||
MIRT501638 | PHLDA3 | pleckstrin homology like domain family A member 3 | 2 | 2 | ||||||||
MIRT512047 | DIRAS2 | DIRAS family GTPase 2 | 2 | 4 | ||||||||
MIRT519877 | ZFP30 | ZFP30 zinc finger protein | 2 | 4 | ||||||||
MIRT522598 | MAP7D1 | MAP7 domain containing 1 | 2 | 4 | ||||||||
MIRT524787 | BAG5 | BCL2 associated athanogene 5 | 2 | 2 | ||||||||
MIRT539158 | AR | androgen receptor | 2 | 2 | ||||||||
MIRT555901 | ORMDL3 | ORMDL sphingolipid biosynthesis regulator 3 | 2 | 2 | ||||||||
MIRT562543 | CCDC71L | coiled-coil domain containing 71 like | 2 | 4 | ||||||||
MIRT568791 | VPS37D | VPS37D, ESCRT-I subunit | 2 | 2 | ||||||||
MIRT569568 | PRELP | proline and arginine rich end leucine rich repeat protein | 2 | 2 | ||||||||
MIRT570000 | COL1A2 | collagen type I alpha 2 chain | 2 | 2 | ||||||||
MIRT570183 | RAP1GAP2 | RAP1 GTPase activating protein 2 | 2 | 2 | ||||||||
MIRT572990 | RPP25 | ribonuclease P and MRP subunit p25 | 2 | 2 | ||||||||
MIRT574618 | LPCAT3 | lysophosphatidylcholine acyltransferase 3 | 2 | 2 | ||||||||
MIRT615354 | CCNF | cyclin F | 2 | 2 | ||||||||
MIRT616091 | HOXB5 | homeobox B5 | 2 | 2 | ||||||||
MIRT617658 | RSRC1 | arginine and serine rich coiled-coil 1 | 2 | 2 | ||||||||
MIRT619107 | CD40LG | CD40 ligand | 2 | 2 | ||||||||
MIRT621198 | ARPC1B | actin related protein 2/3 complex subunit 1B | 2 | 2 | ||||||||
MIRT628839 | FAM151B | family with sequence similarity 151 member B | 2 | 2 | ||||||||
MIRT635552 | LEPREL1 | prolyl 3-hydroxylase 2 | 2 | 2 | ||||||||
MIRT635703 | NMNAT2 | nicotinamide nucleotide adenylyltransferase 2 | 2 | 2 | ||||||||
MIRT646646 | FNBP1 | formin binding protein 1 | 2 | 2 | ||||||||
MIRT654905 | POMGNT1 | protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta 1,2-) | 2 | 2 | ||||||||
MIRT655121 | PHF7 | PHD finger protein 7 | 2 | 2 | ||||||||
MIRT659457 | CLPB | ClpB homolog, mitochondrial AAA ATPase chaperonin | 2 | 4 | ||||||||
MIRT668952 | CNBP | CCHC-type zinc finger nucleic acid binding protein | 2 | 2 | ||||||||
MIRT684242 | TBXA2R | thromboxane A2 receptor | 2 | 2 | ||||||||
MIRT692701 | MEAF6 | MYST/Esa1 associated factor 6 | 2 | 2 | ||||||||
MIRT694328 | CHST6 | carbohydrate sulfotransferase 6 | 2 | 2 | ||||||||
MIRT712137 | TAOK1 | TAO kinase 1 | 2 | 2 | ||||||||
MIRT713672 | SH3PXD2A | SH3 and PX domains 2A | 2 | 2 | ||||||||
MIRT715741 | HSD11B1L | hydroxysteroid 11-beta dehydrogenase 1 like | 2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|